Abstract
Patients receiving high-dose preparation for stem cell transplantation are at risk for organ dysfunction (OD). Signs of early OD include hypoxia, mental status changes, and liver dysfunction. These early signs have not been correlated with potential cytokine mediators. We compared plasma concentrations of IL-6, TNF-α, and IL-10 in OD patients and controls. Cytokines were measured before preparation, 5 days before OD, day of OD, and 5 days after OD. TNF-α and IL-10 were not measurable prior to preparation. IL-10 was more likely to be measurable in OD patients than in controls 5 days prior to onset of OD (P = 0.039), on the day of OD (P = 0.023), and 5 days later (P < 0.0001). TNF-α was more likely to be measurable only on the day of OD (P = 0.0035). IL-6 was significantly elevated in OD patients at all time points. Patients who had measurable IL-6 on admission were 5.1 times more likely to develop OD (95% CI = 1.4–17.9; P = 0.011). Five days prior to OD for each 100 pg/ml increase in IL-6, patients were 2.75 times more likely to develop OD (95% CI = 1.3–5.8; P = 0.0087). The early elevation of IL-6 in patients who develop OD may help identify a high risk group where preventive therapies can be evaluated. Bone Marrow Transplantation (2001) 28, 889–893.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Haire WD, Ruby EI, Gordon BG et al. Multiple organ dysfunction syndrome in bone marrow transplantation J Am Med Assoc 1995 274: 1289–1295
Holler E, Kolb HJ, Moller A et al. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation Blood 1990 75: 1011–1016
Takatsuka H, Takemoto Y, Yamada S et al. Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome Bone Marrow Transplant 2000 26: 419–426
Baker KS, Roncarolo MG, Peters C et al. High spontaneous interleukin-10 production in unrelated bone marrow transplant recipients is associated with fewer transplant-related complications and early deaths Bone Marrow Transplant 1999 23: 1123–1129
Ferrara JL, Levy R, Chao NJ . Pathophysiologic mechanisms of acute graft-versus-host disease Biol Blood Marrow Transplant 1999 5: 347–356
Gordon B, Tarantolo S, Ruby I et al. Increased platelet transfusion requirement is associated with multiple organ dysfunction in patients undergoing stem cell transplantation Bone Marrow Transplant 1998 22: 999–1003
Solovey A, Gui L, Key NS, Hebbel RP . Tissue factor expression by endothelial cells in sickle cell anemia J Clin Invest 1998 101: 1899–1904
Przepiorka D, Dimopoulos M, Smith T et al. Thiotepa, busulfan, and cyclophosphamide as a preparative regimen formarrow transplantation: risk factors for early regimen-relatedtoxicity Ann Hematol 1994 68: 183–188
Chauncey TR, Gooley TA, Lloid ME et al. Pilot trial of cytoprotection with amifostine given with high-dose chemotherapy and autologous peripheral blood stem cell transplantation Am J Clin Oncol 2000 23: 406–411
Ljungman P, Hassan M, Bekassy AN et al. High busulfan concentrations are associated with increased transplant-related mortality in allogeneic bone marrow transplant patients Bone Marrow Transplant 1997 20: 909–913
Szydlo R, Goldman JM, Klein JP et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings J Clin Oncol 1997 15: 1767–1777
Haire WD, Ruby EI, Stephens LC et al. A prospective randomized double-blind trial of antithrombin III concentration in the treatment of multiple organ dysfunction syndrome during hematopoietic stem cell transplantation Biol Blood Marrow Transplant 1998 4: 142–150
Haire WD . The multiple organ dysfunction syndrome in cancer patients undergoing hematopoietic stem cell transplantation Semin Thromb Hemost 1999 25: 223–237
Spriggs DR, Sherman ML, Imamuta K et al. Phospholipase A activation and autoinduction of tumor necrosis factor alpha gene expression by tumor necrosis factor Cancer Res 1990 50: 7101–7107
Gordon B, Lyden E, Lynch J et al. Central nervous system dysfunction as the first manifestation of multiple organ dysfunction syndrome in stem cell transplant patients Bone Marrow Transplant 2000 25: 79–83
Parsons PE . Mediators and mechanisms of acute lung injury Clin Chest Med 2000 21: 467–476
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McGuire, T., Bociek, G., Pavletic, S. et al. Organ dysfunction following stem cell transplantation: relationship to plasma cytokine concentrations. Bone Marrow Transplant 28, 889–893 (2001). https://doi.org/10.1038/sj.bmt.1703238
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703238
Keywords
This article is cited by
-
TNF inhibits catecholamine production from induced sympathetic neuron-like cells in rheumatoid arthritis and osteoarthritis in vitro
Scientific Reports (2018)
-
Septic shock and multiple organ failure after hematopoietic stem cell transplantation: treatment with recombinant human activated protein C
Bone Marrow Transplantation (2002)